These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 18414141

  • 21. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
    Baron BM, Harrison BL, McDonald IA, Meldrum BS, Palfreyman MG, Salituro FG, Siegel BW, Slone AL, Turner JP, White HS.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):947-56. PubMed ID: 1388205
    [Abstract] [Full Text] [Related]

  • 22. Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations.
    Kure S, Rolland MO, Leisti J, Mandel H, Sakata Y, Tada K, Matsubara Y, Narisawa K.
    Prenat Diagn; 1999 Aug; 19(8):717-20. PubMed ID: 10451514
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.
    Karcz-Kubicha M, Wedzony K, Zajaczkowski W, Danysz W.
    J Neural Transm (Vienna); 1999 Aug; 106(11-12):1189-204. PubMed ID: 10651113
    [Abstract] [Full Text] [Related]

  • 25. Glycine binding sites of presynaptic NMDA receptors may tonically regulate glutamate release in the rat visual cortex.
    Li YH, Han TZ.
    J Neurophysiol; 2007 Jan; 97(1):817-23. PubMed ID: 17093111
    [Abstract] [Full Text] [Related]

  • 26. d-Glyceric aciduria does not cause nonketotic hyperglycinemia: A historic co-occurrence.
    Swanson MA, Garcia SM, Spector E, Kronquist K, Creadon-Swindell G, Walter M, Christensen E, Van Hove JLK, Sass JO.
    Mol Genet Metab; 2017 Jun; 121(2):80-82. PubMed ID: 28462797
    [Abstract] [Full Text] [Related]

  • 27. Cell signalling and the hormonal stimulation of the hepatic glycine cleavage enzyme system by glucagon.
    Mabrouk GM, Jois M, Brosnan JT.
    Biochem J; 1998 Mar 01; 330 ( Pt 2)(Pt 2):759-63. PubMed ID: 9480887
    [Abstract] [Full Text] [Related]

  • 28. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
    Kawaura K, Koike H, Kinoshita K, Kambe D, Kaku A, Karasawa J, Chaki S, Hikichi H.
    Behav Brain Res; 2015 Feb 01; 278():186-92. PubMed ID: 25300471
    [Abstract] [Full Text] [Related]

  • 29. Depletion of cerebral D-serine in non-ketotic hyperglycinemia: possible involvement of glycine cleavage system in control of endogenous D-serine.
    Iwama H, Takahashi K, Kure S, Hayashi F, Narisawa K, Tada K, Mizoguchi M, Takashima S, Tomita U, Nishikawa T.
    Biochem Biophys Res Commun; 1997 Feb 24; 231(3):793-6. PubMed ID: 9070895
    [Abstract] [Full Text] [Related]

  • 30. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC, Kemp JA, Leeson PD, Grimwood S, Donald AE, Marshall GR, Priestley T, Smith JD, Carling RW.
    Mol Pharmacol; 1992 May 24; 41(5):914-22. PubMed ID: 1375317
    [Abstract] [Full Text] [Related]

  • 31. Role of the glycine-cleavage system in glycine and serine metabolism in various organs.
    Kikuchi G, Hiraga K, Yoshida T.
    Biochem Soc Trans; 1980 Oct 24; 8(5):504-6. PubMed ID: 6778735
    [No Abstract] [Full Text] [Related]

  • 32. Glycine metabolism in anaerobes.
    Andreesen JR.
    Antonie Van Leeuwenhoek; 1994 Oct 24; 66(1-3):223-37. PubMed ID: 7747933
    [Abstract] [Full Text] [Related]

  • 33. The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies.
    Hesselink MB, Smolders H, Eilbacher B, De Boer AG, Breimer DD, Danysz W.
    J Pharmacol Exp Ther; 1999 Aug 24; 290(2):543-50. PubMed ID: 10411561
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learning.
    Viu E, Zapata A, Capdevila J, Skolnick P, Trullas R.
    Neurobiol Learn Mem; 2000 Sep 24; 74(2):146-60. PubMed ID: 10933900
    [Abstract] [Full Text] [Related]

  • 36. [3H](+)MK801 radioligand binding assay at the N-methyl-D-aspartate receptor.
    Reynolds IJ.
    Curr Protoc Pharmacol; 2001 May 24; Chapter 1():Unit 1.20. PubMed ID: 22293962
    [Abstract] [Full Text] [Related]

  • 37. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
    Christensen D, Idänpään-Heikkilä JJ, Guilbaud G, Kayser V.
    Br J Pharmacol; 1998 Dec 24; 125(8):1641-50. PubMed ID: 9886755
    [Abstract] [Full Text] [Related]

  • 38. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
    Manahan-Vaughan D, Wildförster V, Thomsen C.
    Eur J Neurosci; 2008 Oct 24; 28(7):1342-50. PubMed ID: 18973561
    [Abstract] [Full Text] [Related]

  • 39. Effect of NG-nitro-L-arginine on age-related changes of glutamate receptor systems and immunophilin in rats.
    Araki T, Oshima Y, Kato H, Shuto K, Itoyama Y.
    Methods Find Exp Clin Pharmacol; 1997 Oct 24; 19(6):373-81. PubMed ID: 9385586
    [Abstract] [Full Text] [Related]

  • 40. Non-ketotic hyperglycinaemia: clinical and biochemical aspects.
    Tada K, Hayasaka K.
    Eur J Pediatr; 1987 May 24; 146(3):221-7. PubMed ID: 3297708
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.